Palatin Technologies Company Profile (NYSE:PTN)

About Palatin Technologies (NYSE:PTN)

Palatin Technologies logoPalatin Technologies, Inc. is a biopharmaceutical company. The Company is engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Its programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. The Company's primary product in clinical development is bremelanotide for the treatment of premenopausal women with hypoactive sexual desire disorder (HSDD), which is a type of female sexual dysfunction (FSD) defined as low desire with associated distress. Its other drug development programs include Melanocortin receptor-4 (MC4r), PL-3994 and Melanocortin receptor-1 (MC1r). MC4r is a compound used for treatment of obesity and diabetes. PL-3994 is a subcutaneously injected guanylate-cyclase type A (GC-A) receptor agonist. MC1r agonist peptides are used for treatment of inflammatory and dermatologic disease indications.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: NYSE:PTN
  • CUSIP: N/A
  • Web:
  • Market Cap: $52.5 million
  • Outstanding Shares: 137,947,000
Average Prices:
  • 50 Day Moving Avg: $0.39
  • 200 Day Moving Avg: $0.44
  • 52 Week Range: $0.29 - $0.90
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 38.06
  • P/E Growth: 0.0000
Sales & Book Value:
  • Annual Revenue: N/A
  • Price / Sales: N/A
  • Book Value: ($0.12) per share
  • Price / Book: -3.17
  • EBIDTA: ($46,650,000.00)
  • Average Volume: 2.18 million shs.
  • Short Ratio: 4.38

Frequently Asked Questions for Palatin Technologies (NYSE:PTN)

What is Palatin Technologies' stock symbol?

Palatin Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "PTN."

How were Palatin Technologies' earnings last quarter?

Palatin Technologies, Inc. (NYSE:PTN) released its earnings results on Thursday, May, 18th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.10 by $0.12. The firm earned $10.82 million during the quarter, compared to the consensus estimate of $60 million. During the same period in the previous year, the company posted ($0.01) earnings per share. View Palatin Technologies' Earnings History.

Where is Palatin Technologies' stock going? Where will Palatin Technologies' stock price be in 2017?

2 brokers have issued 1 year target prices for Palatin Technologies' stock. Their forecasts range from $0.55 to $6.00. On average, they expect Palatin Technologies' stock price to reach $2.68 in the next twelve months. View Analyst Ratings for Palatin Technologies.

Are investors shorting Palatin Technologies?

Palatin Technologies saw a increase in short interest in May. As of May 15th, there was short interest totalling 10,056,495 shares, an increase of 13.5% from the April 28th total of 8,860,354 shares. Based on an average trading volume of 2,453,264 shares, the short-interest ratio is presently 4.1 days. Currently, 7.6% of the shares of the stock are sold short.

Who are some of Palatin Technologies' key competitors?

Who owns Palatin Technologies stock?

Palatin Technologies' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (3.28%), Sphera Funds Management LTD. (2.11%), Sabby Management LLC (1.47%), Geode Capital Management LLC (0.49%), California Public Employees Retirement System (0.35%) and National Asset Management Inc. (0.23%). Company insiders that own Palatin Technologies stock include Joseph Stanley Hull and Robert K Deveer Jr. View Institutional Ownership Trends for Palatin Technologies.

Who bought Palatin Technologies stock? Who is buying Palatin Technologies stock?

Palatin Technologies' stock was purchased by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Sabby Management LLC and National Asset Management Inc.. Company insiders that have bought Palatin Technologies stock in the last two years include Joseph Stanley Hull and Robert K Deveer Jr. View Insider Buying and Selling for Palatin Technologies.

How do I buy Palatin Technologies stock?

Shares of Palatin Technologies can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Palatin Technologies stock cost?

One share of Palatin Technologies stock can currently be purchased for approximately $0.38.

Analyst Ratings

Consensus Ratings for Palatin Technologies (NYSE:PTN) (?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $2.68 (605.03% upside)

Analysts' Ratings History for Palatin Technologies (NYSE:PTN)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/16/2017Canaccord GenuitySet Price TargetBuy$6.00LowView Rating Details
1/25/2017Roth CapitalReiterated RatingBuy$1.50N/AView Rating Details
9/22/2016S&P Equity ResearchLower Price Target$0.61 -> $0.55N/AView Rating Details
8/19/2015Noble FinancialReiterated RatingBuy$3.50 -> $4.00N/AView Rating Details
8/19/2015Piper Jaffray CompaniesReiterated RatingOverweight$4.00N/AView Rating Details
(Data available from 5/25/2015 forward)


Earnings History for Palatin Technologies (NYSE:PTN)
Earnings by Quarter for Palatin Technologies (NYSE:PTN)
Earnings History by Quarter for Palatin Technologies (NYSE:PTN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/18/2017Q3 2017$0.10($0.02)$60.00 million$10.82 millionViewN/AView Earnings Details
2/9/2017Q2 2017($0.07)($0.06)ViewListenView Earnings Details
11/15/2016Q117($0.08)($0.08)ViewN/AView Earnings Details
9/20/2016Q416($0.08)($0.09)ViewListenView Earnings Details
5/17/2016Q316($0.08)($0.08)ViewN/AView Earnings Details
2/16/2016Q216($0.07)($0.08)ViewN/AView Earnings Details
11/12/2015Q116($0.08)($0.08)ViewListenView Earnings Details
9/21/2015Q415($0.06)($0.09)$2.05 million$12.95 millionViewListenView Earnings Details
5/13/2015Q315($0.04)($0.07)$0.41 millionViewListenView Earnings Details
2/13/2015Q115$0.01$0.03$5.40 million$4.90 millionViewN/AView Earnings Details
11/18/2014Q1 15$0.04$0.01$9.00 million$4.93 millionViewN/AView Earnings Details
9/9/2014Q4 14$0.03($0.04)ViewN/AView Earnings Details
5/13/2014Q3($0.03)($0.01)$500.00 millionViewListenView Earnings Details
11/14/2013Q1($0.05)($0.04)ViewListenView Earnings Details
10/1/2013Q413($0.05)($0.04)ViewListenView Earnings Details
5/14/2013Q3 2013($0.05)($0.04)$0.02 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Palatin Technologies (NYSE:PTN)
Current Year EPS Consensus Estimate: $-0.0700 EPS
Next Year EPS Consensus Estimate: $0.0100 EPS


Dividend History for Palatin Technologies (NYSE:PTN)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Palatin Technologies (NYSE:PTN)
Insider Trades by Quarter for Palatin Technologies (NYSE:PTN)
Institutional Ownership by Quarter for Palatin Technologies (NYSE:PTN)
Insider Trades by Quarter for Palatin Technologies (NYSE:PTN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/4/2015Joseph Stanley HullDirectorBuy2,500$0.66$1,650.00View SEC Filing  
10/2/2015Robert K Deveer JrDirectorBuy10,000$0.82$8,200.00View SEC Filing  
2/26/2014Bvf Partners L P/IlMajor ShareholderSell540,181$1.14$615,806.34View SEC Filing  
2/19/2014Bvf Partners L P/IlMajor ShareholderSell305,966$1.17$357,980.22View SEC Filing  
3/19/2013Alan W DuntonDirectorBuy1,000$0.58$580.00View SEC Filing  
2/1/2013Alan W DuntonDirectorBuy2,000$0.59$1,180.00View SEC Filing  
1/28/2013Robert I TaberDirectorBuy5,000$0.59$2,950.00View SEC Filing  
12/31/2012Carl SpanaCEOBuy10,000$0.57$5,700.00View SEC Filing  
12/28/2012Stephen T WillsCFOBuy10,000$0.56$5,600.00View SEC Filing  
12/24/2012Perry B MolinoffDirectorBuy10,000$0.61$6,100.00View SEC Filing  
12/14/2012Robert K Deveer JrDirectorBuy21,960$0.70$15,372.00View SEC Filing  
9/4/2012Alan W DuntonDirectorBuy1,000$0.58$580.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Palatin Technologies (NYSE:PTN)
Latest Headlines for Palatin Technologies (NYSE:PTN)
DateHeadline logoPalatin Technologies, Inc. (PTN) Short Interest Update - May 24 at 6:58 PM logoPalatin Technologies, Inc. (PTN) PT Set at $6.00 by Canaccord Genuity - May 17 at 7:10 PM logoPalatin Technologies, Inc. (PTN) Announces Earnings Results - May 17 at 10:02 AM logoPalatin Technologies, Inc. Reports Third Quarter Fiscal Year 2017 ... - PR Newswire (press release) - May 17 at 12:05 AM logoEdited Transcript of PTN earnings conference call or presentation 16-May-17 3:00pm GMT - May 17 at 12:05 AM logoEARNINGS SUMMARY: Details of Palatin Technologies Inc. Q3 Earnings Report - May 16 at 7:03 PM logoPalatin Technologies, Inc. Reports Third Quarter Fiscal Year 2017 Results; Teleconference and Webcast to be held on May 16, 2017 - May 16 at 9:44 AM logoPalatin Technologies, Inc. to Report Third Quarter Fiscal Year 2017 Results; Teleconference and Webcast to be held on May 16, 2017 - May 11 at 8:27 AM logoPalatin Technologies (PTN) Receives Daily Media Sentiment Score of 0.10 - April 29 at 11:57 PM logoSomewhat Positive Media Coverage Very Likely to Affect Palatin Technologies (PTN) Share Price - April 26 at 9:34 PM logoPalatin Technologies (PTN) Earns Daily News Impact Rating of 0.17 - April 18 at 12:57 AM logoShort Interest in Palatin Technologies, Inc. (PTN) Increases By 1.2% - April 11 at 7:36 PM logoPalatin Technologies to Present at The MicroCap Conference on April 4th at 1:00 PM ET in New York City at the Essex House - March 31 at 7:32 PM logoCanaccord Genuity Reiterates $6.00 Price Target for Palatin Technologies, Inc. (PTN) - March 26 at 9:46 PM logoShort Interest in Palatin Technologies, Inc. (PTN) Declines By 2.3% - March 25 at 7:14 AM logoPalatin Technologies (PTN) Reports Methods of Use Patent for Treatment of HSDD in Premenopausal Women - - March 23 at 12:21 AM logoPalatin Technologies Receives Notice of Allowance on Bremelanotide Methods of Use Patent for Treatment of Hypoactive Sexual Desire Disorder in Premenopausal Women - March 20 at 9:26 AM logo7:31 am Palatin Technologies announces that the USPTO has issued a NOA for U.S. Patent Application Serial Number 14/704,223 for the treatment of hypoactive sexual desire disorder in premenopausal women - March 20 at 9:26 AM logoHealthcare Stocks on Investors' Radar -- Delcath Systems, Palatin Technologies, AMAG Pharma, and IDEXX Laboratories - March 14 at 10:04 AM logoShort Interest in Palatin Technologies, Inc. (PTN) Grows By 22.0% - March 9 at 6:30 PM logoAMAG Pharma (AMAG), Palatin (PTN) Announce Rekynda Data Presentations at ISSWSH Meeting - February 27 at 4:13 PM logoAMAG, Palatin Say Both Phase 3 RECONNECT Studies Met Co-primary End Points - February 27 at 9:41 AM logoAMAG and Palatin Announce Rekynda™ Data Presentations at the International Society for the Study of Women’s Sexual Health Annual Meeting - February 27 at 9:41 AM logoAMAG Inks $60M Women's Health Drug Deal (AMAG) - February 16 at 6:59 PM logoPALATIN TECHNOLOGIES INC Financials - February 16 at 6:59 PM logoPALATIN TECHNOLOGIES INC Files SEC form 10-Q, Quarterly Report - February 10 at 9:45 PM logoEARNINGS SUMMARY: Details of Palatin Technologies Inc. Q2 Earnings Report - February 10 at 3:11 AM logoPalatin Technologies' (PTN) CEO Carl Spana on Q2 2017 Results - Earnings Call Transcript - Seeking Alpha - February 9 at 10:08 PM logoQ2 2017 Palatin Technologies Inc Earnings Release - Before Market Open - February 9 at 10:08 PM logoPalatin Technologies, Inc. Reports Second Quarter Fiscal Year 2017 Results; Teleconference and Webcast to be held on February 9, 2017 - February 9 at 10:08 PM logoPALATIN TECHNOLOGIES INC Files SEC form 8-K, Results of Operations and Financial Condition - February 9 at 10:08 PM logoPALATIN TECHNOLOGIES INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits - February 8 at 9:32 PM logoPalatin Technologies (PTN) Closes License Agreement for Rekynda Rights with AMAG Pharmaceuticals (AMAG) - February 3 at 8:14 PM logoPalatin (PTN) Sees Hammer Chart Pattern: Time to Buy? - February 2 at 9:11 PM



Palatin Technologies (PTN) Chart for Thursday, May, 25, 2017

This page was last updated on 5/25/2017 by Staff